Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.

Abstract excerpt

Swen et al.1 examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Related Side Effects and Adverse Reactions
• Share to Genotype
• Share to Pharmacogenetics